Anheuser-Busch InBev, makers of global beer brand, Budweiser, has agreed to a $100 million partnership with medical cannabis company Tilray to research marijuana-infused drinks for the Canadian market.
AB InBev and Tilray in announced on Wednesday that each company will commit a $50 million investment to the project.
Both companies will study non-alcoholic beverages containing cannabidiol, or CBD and THC in a bid to manufacture cannabis-infused beer.
Canada has legalized recreational marijuana leading to increased interest from beer and tobacco companies to capitalise on opportunities within the market.
